<DOC>
	<DOCNO>NCT00093847</DOCNO>
	<brief_summary>This study determine effectiveness add S-adenosyl methionine antidepressant drug treatment reduce depressive symptom depressed people respond antidepressant alone .</brief_summary>
	<brief_title>Optimizing Effectiveness Selective Serotonin Reuptake Inhibitors ( SSRIs ) Treatment-Resistant Depression</brief_title>
	<detailed_description>Some people depression respond well antidepressant treatment . S-adenosyl methionine ( SAMe ) naturally occur compound may antidepressant effect . SAMe may also enhance effectiveness antidepressant , selective serotonin reuptake inhibitor ( SSRIs ) . This study determine effectiveness oral SAMe enhance effect SSRIs patient currently respond SSRI treatment . This study last 6 week . No follow-up visit occur . Participants randomly assign add either oral SAMe placebo exist SSRI regimen 6 week . Depression scale self-report questionnaire regard depressive symptom use ass participant end study .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Treatment-Resistant</mesh_term>
	<mesh_term>Serotonin</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<criteria>Major depressive disorder Use SSRI least 6 week prior study entry partial response History psychosis Allergy SAMe Alcohol drug abuse past 3 month prior study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Selective Serotonin Reuptake Inhibitors</keyword>
	<keyword>S-adenosyl Methionine</keyword>
	<keyword>SSRI</keyword>
	<keyword>SAMe</keyword>
</DOC>